As of November 6, 2026, Dare Bioscience, Inc. is a publicly traded company (Nasdaq: DARE); its largest reported holder is L1 Capital Global Opportunities Master Fund, Ltd., with 9.99% on Schedule 13G of August 24, 2026, then Lind Global Fund III LP (5.65%) (Schedule 13G, August 24, 2026).
Is this your company?
About to sign with, pay or invest in Dare Bioscience, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Dare Bioscience, Inc. a real, registered company?
- Dare Bioscience, Inc. files with the SEC under CIK 1401914 (its SEC filings).
- Its shares are listed under the ticker DARE on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in San Diego, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Dare Bioscience, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Lind Global Fund III LP (filed 2026-08-28).
Who are Dare Bioscience, Inc.'s owners and officers?
Dare Bioscience, Inc.: incorporated in Delaware; business address in San Diego, California; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-28).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2026-08-20)
- : Executive Officer (Form D, 2026-08-20)
- : Director (Form D, 2026-08-20)
- : Director (Form D, 2026-08-20)
- : Director (Form D, 2026-08-20)
- : Director (Form D, 2026-08-20)
- : Director (Form D, 2026-08-20)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-28 | Lind Global Fund Iii LP | 5.65% |
| Schedule 13G, 2026-08-24 | L1 Capital Global Opportunities Master Fund, LTD. | 9.99% |
| Schedule 13G/A, 2025-12-23 | Law Custodial Inc. | — |
| Schedule 13G, 2025-10-06 | Law Custodial Inc. | 15.9% |
Questions about who owns Dare Bioscience, Inc.
Who owns Dare Bioscience, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Dare Bioscience, Inc.: L1 Capital Global Opportunities Master Fund, LTD. (9.99%, Schedule 13G, filed 2026-08-24) and Lind Global Fund Iii LP (5.65%, Schedule 13G, filed 2026-08-28).
Who are the largest shareholders of Dare Bioscience, Inc.?
By the share each holder's latest filing reports, the largest holders of Dare Bioscience, Inc. on this page are L1 Capital Global Opportunities Master Fund, LTD. (9.99%) and Lind Global Fund Iii LP (5.65%).
When did L1 Capital Global Opportunities Master Fund, LTD. buy into Dare Bioscience, Inc.?
The filings give report dates, not purchase dates. The earliest filing from L1 Capital Global Opportunities Master Fund, LTD. on this page is the Schedule 13G, filed 2026-08-24, reporting 9.99%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Dare Bioscience, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Dare Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dare Bioscience, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Dare Bioscience, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 47,055 shares (0.31% of shares outstanding) (Form 4, 2026-07-02).
- , a director: 39,721 shares (0.26% of shares outstanding) (Form 4, 2026-07-02).
- , a director: 30,847 shares (0.20% of shares outstanding) (Form 4, 2026-07-02).
- , a director: 26,066 shares (0.17% of shares outstanding) (Form 4, 2026-07-02).
- , a director: 23,696 shares (0.15% of shares outstanding) (Form 4, 2026-07-02).
Shares outstanding: 15,289,502 as of 2026-08-12, from the company's latest SEC cover page.
How much has Dare Bioscience, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-08-20 | $12.38M | $12.38M |
| Form D, 2024-11-22 | $0 | $15M |
| Form D, 2023-12-26 | $1.73M | $4.16M |
Latest IPO step: Dare Bioscience, Inc. filed to go public (S-1, 2026-08-26).
IPO filings: S-1, 2026-08-26, S-1, 2024-11-15; ticker DARE on Nasdaq Capital Market.
Keep reading
More on Dare Bioscience, Inc. and the records around it.
The people at Dare Bioscience, Inc.
- William Rastetter is also named on 6 other Form D filings: Iambic Therapeutics, Inc. (Sep 2026)
Dare Bioscience, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Company profile and every filing Aug 2026
- Form D filing Aug 2026
Companies that share a holder
- Lind Global Fund III LP also filed stake reports on 11 other companies: DEFSEC Technologies Inc. (Aug 2026), Enveric Biosciences, Inc. (Aug 2026), Iveda Solutions, Inc. (Aug 2026)
- L1 Capital Global Opportunities Master Fund, Ltd. also filed stake reports on 42 other companies: Youlife Group Inc. (Nov 2026), INLIF Ltd (Oct 2026), DarkIris Inc. (Oct 2026)
Related pages
Funding and filing history5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/dare-bioscience-inc